Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRRK2 screening in a Canadian Parkinson's disease cohort.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques - 1 Aug 2007

Grimes D A, Racacho L, Han F, Panisset M, Bulman D E

Abstract excerpt

BACKGROUND: Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have become the most common known cause for developing Parkinson's disease. The frequency of mutations described in the literature varies widely depending on the population studied with most reports focusing only on screening for the most common G2019S mutation in exon 41. METHODS: In this study seven exons (19, 24, 25, 31, 35, 38, and 41) in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Canada
Share to Chromatography, High Pressure Liquid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Introns

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Parkinson Disease

Share to Predictive Value of Tests

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 17803033
DOI: 10.1017/s0317167100006788

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRRK2 screening in a Canadian Parkinson's disease cohort.PMID 17803033Read ↗

LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.Semantic proximity Read ↗

Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.Semantic proximity Read ↗

Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson’s diseaseSemantic proximity Read ↗

A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.Semantic proximity Read ↗

Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.Semantic proximity Read ↗

Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.Semantic proximity Read ↗

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.Semantic proximity Read ↗

A study of LRRK2 mutations and Parkinson's disease in Brazil.Semantic proximity Read ↗

A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.Semantic proximity Read ↗

Genetic testing of LRRK2 in Parkinson's disease: is there a clinical role?Semantic proximity Read ↗

A clinic-based screening of mutations in exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's disease patients.Semantic proximity Read ↗

Test for LRRK2 mutations in patients with Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.